genOway SA Stock Xetra
Equities
JEH
FR0004053510
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
Sales 2022 | 21.09M 22.65M | Sales 2023 | 26.51M 28.47M | Capitalization | 40.59M 43.6M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | 1M 1.07M | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 4.16M 4.46M | Net Debt 2023 | 2.97M 3.19M | EV / Sales 2023 | 1.64 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 99-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 99-02-28 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
1st Jan change | Capi. | |
---|---|---|
+34.01% | 52.85B | |
-8.02% | 38.87B | |
+34.86% | 38.24B | |
-11.12% | 26.79B | |
+12.56% | 26.16B | |
-19.62% | 19.9B | |
+39.18% | 13.18B | |
+31.47% | 12.24B | |
-3.40% | 11.79B |
- Stock Market
- Equities
- ALGEN Stock
- JEH Stock